← Back to Search

Exoskeleton

Hand Exoskeleton for Stroke Rehabilitation

N/A
Waitlist Available
Led By Na Jin Seo, PhD MS BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to move fingers (Chedoke-McMaster Hand Section Stage 2-4)
Be older than 18 years old
Must not have
Inability to follow 2-step commands
Severe muscle tone prohibiting proper placement of the fingers (Modified Ashworth Scale, MAS=5 out of 5)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the 1st half to the 2nd half of the 1-hour training session
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new exercise tool to help Veterans recovering from a stroke improve their finger movements. The tool uses special controllers to guide finger exercises, aiming to enhance hand function and independence.

Who is the study for?
This trial is for adult veterans who had a stroke between 1-6 months ago and can move their fingers somewhat (Chedoke-McMaster Hand Section Stage 2-4). It's not suitable for those who can't follow simple commands or have severe muscle stiffness preventing finger placement, or recent changes in spasticity medication.
What is being tested?
The SPiRE Maestro Hand Exoskeleton is being tested as a new rehabilitation tool to improve hand function by enhancing finger joint coordination in individuals recovering from a stroke.
What are the potential side effects?
While the trial description does not specify side effects, typical concerns with exoskeleton use may include discomfort at contact points, skin irritation, or fatigue due to training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can move my fingers but with some difficulty.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot follow 2-step commands.
Select...
My fingers are very stiff, making it hard to move them.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the 1st half to the 2nd half of the 1-hour training session
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the 1st half to the 2nd half of the 1-hour training session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
change in finger joint torque assistance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: single armExperimental Treatment1 Intervention
All participants will receive assistance to move finger joints away from the compensatory coordination (compensation avoidance), toward the desired trajectories (task assistance), both, and none in different days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exoskeleton
2018
N/A
~70

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Stroke rehabilitation often involves targeted exercises to improve motor function, such as repetitive hand and finger movements against various loads. These exercises work by enhancing neural plasticity, which is the brain's ability to reorganize itself by forming new neural connections. This is crucial for stroke patients as it helps restore motor skills and improve coordination, thereby increasing independence and quality of life. The use of tools like the SPiRE Maestro Hand Exoskeleton can further aid in this process by providing consistent and precise movements, which are essential for effective rehabilitation.
Repetitive training of isolated movements improves the outcome of motor rehabilitation of the centrally paretic hand.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,666 Total Patients Enrolled
86 Trials studying Stroke
6,878 Patients Enrolled for Stroke
Na Jin Seo, PhD MS BSPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
2 Previous Clinical Trials
113 Total Patients Enrolled
2 Trials studying Stroke
113 Patients Enrolled for Stroke

Media Library

SPiRE Maestro Hand Exoskeleton (Exoskeleton) Clinical Trial Eligibility Overview. Trial Name: NCT04978467 — N/A
Stroke Research Study Groups: single arm
Stroke Clinical Trial 2023: SPiRE Maestro Hand Exoskeleton Highlights & Side Effects. Trial Name: NCT04978467 — N/A
SPiRE Maestro Hand Exoskeleton (Exoskeleton) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04978467 — N/A
~0 spots leftby Dec 2025